Safety of hymenoptera venom immunotherapy: A systematic review

Expert Opinion on Pharmacotherapy

Volumn 12, Issue 16, 2011, Pages 2527-2532

  Incorvaia, Cristoforo ^a   Frati, Franco ^b   Dell'Albani, Ilaria ^b   Robino, Anna ^c   Cattaneo, Eleonora ^b   Mauro, Marina ^d   David, Marie ^e   Qualizza, Rosanna ^a   Pastorello, Elide ^c  

^a PARKINSON INSTITUTE   (Italy)

^b Scientific Department   (Italy)

^c OSPEDALE NIGUARDA CA GRANDA   (Italy)

^d SANT ANNA HOSPITAL   (Italy)

^e Stallergenes SA   (France)

Author keywords

aqueous; depot; honeybee; hymenoptera venom; systemic reactions; venom immunotherapy; vespids

Indexed keywords

ALLERGEN; BEE VENOM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYMENOPTERA VENOM;

DRUG HYPERSENSITIVITY; DRUG SAFETY; HONEYBEE; HUMAN; HYMENOPTERA; IMMUNOTHERAPY; INCIDENCE; INSECT ALLERGY; MEDLINE; POPULATION; REVIEW; SYSTEMATIC REVIEW;

ALLERGENS; ANIMALS; BEE VENOMS; BEES; HUMANS; HYPERSENSITIVITY, IMMEDIATE; IMMUNOTHERAPY; INSECT BITES AND STINGS; WASP VENOMS; WASPS;

EID: 80054084053     PISSN: 14656566     EISSN: 17447666     Source Type: Journal    
DOI: 10.1517/14656566.2011.616494     Document Type: Review

References (37)

1. Antonicelli L, Bilo MB, Bonifazi F. Epidemiology of Hymenoptera allergy. Curr Opin Allergy Clin Immunol 2002;2:341-6 (Pubitemid 36869643)
2. Hunt KJ, Valentine MD, Sobotka AK, et al. A controlled trial of immunotherapy in insect hypersensitivity. N Engl J Med 1978;299:157-61 (Pubitemid 8396220)
3. Ross RN, Nelson HS, Finegold I. Effectiveness of specific immunotherapy in the treatment of hymenoptera venom hypersensitivity: a meta-analysis. Clin Ther 2000;22:351-8 (Pubitemid 30213141)
4. Lerch E, Muller UR. Long-term protection after stopping venom immunotherapy: results of re-sting in 200 patients. J Allergy Clin Immunol 1998;101:606-12
5. Golden DB, Kagey-Sobotka A, Lichtenstein LM. Survey of patients after discontinuing venom immunotherapy. J Allergy Clin Immunol 2000;105:385-90 (Pubitemid 30109056)
6. Bonifazi F, Jutel M, Bilo MB, et al. Prevention and treatment of hymenoptera venom allergy: guidelines for clinical practice. Allergy 2005;60:1459-70 (Pubitemid 41654315)
7. Reimers A, Hari Y, Muller U. Reduction of side-effects from ultrarush immunotherapy with honeybee venom by pretreatment with fexofenadine: a double-blind, placebo-controlled trial. Allergy 2000;55:484-8 (Pubitemid 30230359)
8. Brockow K, Kiehn M, Riethmuller C, et al. Efficacy of antihistamine pretreatment in the prevention of adverse reactions to Hymenoptera immunotherapy: a prospective, randomized, placebo-controlled trial. J Allergy Clin Immunol 1997;100:458-63
9. Muller U, Lanner A, Schmid P, et al. A double blind study on immunotherapy with chemically modified honey bee venom: monomethoxy polyethylene glycol-coupled versus crude honey bee venom. Int Arch Allergy Appl Immunol 1985;77:201-3 (Pubitemid 15027276)
10. Muller U, Akdis CA, Fricker M, et al. Successful immunotherapy with T-cell epitope peptides of bee venom phospholipase A2 induces specific T-cell anergy in patients allergic to bee venom. J Allergy Clin Immunol 1998;101:747-54
11. Mosbech H, Malling HJ, Biering I, et al. Immunotherapy with yellow jacket venom. A comparative study including three different extracts, one adsorbed to aluminium hydroxide and two unmodified. Allergy 1986;41:95-103 (Pubitemid 16044349)
12. Mellerup MT, Hahn GW, Poulsen LK, Malling H. Safety of allergen-specific immunotherapy. Relation between dosage regimen, allergen extract, disease and systemic side effects during induction treatment. Clin Exp Allergy 2000;30:1423-9
13. Lockey RF, Turkeltaub PC, Olive ES, et al. The Hymenoptera venom study. III: Safety of venom immunotherapy. J Allergy Clin Immunol 1990;86:775-80
14. Muller U, Helbling A, Berchtold E. Immunotherapy with honeybee venom and yellow jacket venom is different regarding efficacy and safety. J Allergy Clin Immunol 1992;89:529-35
15. Birnbaum J, Charpin D, Vervloet D. Rapid Hymenoptera venom immunotherapy: comparative safety of three protocols. Clin Exp Allergy 1993;23:226-30 (Pubitemid 23112346)
16. Bernstein JA, Kagen SL, Bernstein DI, Bernstein IL. Rapid venom immunotherapy is safe for routine use in the treatment of patients with Hymenoptera anaphylaxis. Ann Allergy 1994;73:423-8 (Pubitemid 24368197)
17. Youlten LJF, Atkinson BA, Lee TH. The incidence and nature of adverse reactions to injection immunotherapy in bee and wasp venom allergy. Clin Exp Allergy 1995;25:159-65
18. Laurent J, Smiejan JM, Bloch-Morot E, et al. Safety of Hymenoptera venom rush immunotherapy. Allergy 1997;52:94-6 (Pubitemid 27120630)
19. Quercia O, Rafanelli S, Puccinelli P, Stefanini GF. The safety of cluster immunotherapy with aluminium hydroxide-adsorbed honey bee venom extract. J Investig Allergol Clin Immunol 2001;11:27-33 (Pubitemid 32586096)
20. Sturm G, Kranke B, Rudolph C, Aberer W. Rush Hymenoptera venom immunotherapy: a safe and practical protocol for high-risk patients. J Allergy Clin Immunol 2002;110:928-33 (Pubitemid 36005882)
21. Birnbaum J, Ramadour M, Magnan A, Vervloet D. Hymenoptera ultra-rush venom immunotherapy (210 min): a safety study and risk factors. Clin Exp Allergy 2003;33:58-64 (Pubitemid 36114908)
22. Wenzel J, Meissner-Kraemer M, Bauer R, et al. Safety of rush insect venom immunotherapy. The results of a retrospective study in 178 patients. Allergy 2003;58:1176-9 (Pubitemid 37372305)
23. Rueff F, Wolf H, Schnitker J, et al. Specific immunotherapy in honeybee venom allergy: a comparative study using aqueous and aluminium hydroxide adsorbed preparations. Allergy 2004;59:589-95 (Pubitemid 38748057)
24. Schiavino D, Nucera E, Pollastrini E, et al. Specific ultrarush desensitization in Hymenoptera venom-allergic patients. Ann Allergy Asthma Immunol 2004;92:409-13 (Pubitemid 39077581)
25. Steiss JO, Jodicke B, Lindemann H. A modified ultrarush insect venom immunotherapy protocol for children. Allergy Asthma Proc 2006;27:148-50 (Pubitemid 43700867)
26. Pasaoglu G, Sin BA, Misirligil Z. Rush hymenoptera venom immunotherapy is efficacious and safe. J Investig Allergol Clin Immunol 2006;16:232-8 (Pubitemid 44198444)
27. Roll A, Hofbauer G, Ballmer-Weber BK, Schmid-Grendelmeier P. Safety of specific immunotherapy using a four-hour ultra-rush induction scheme in bee and wasp allergy. J Investig Allergol Clin Immunol 2006;16:79-85 (Pubitemid 43807147)
28. Quercia O, Emiliani F, Pecora S, et al. Efficacy, safety, and modulation of immunologic markers by immunotherapy with honeybee venom: comparison of standardized quality depot versus aqueous extract. Allergy Asthma Proc 2006;27:151-8 (Pubitemid 43700868)
29. Alessandrini AE, Berra D, Lodi Rizzini F, et al. Flexible approaches in the design of subcutaneous immunotherapy protocols for Hymenoptera venom allergy. Ann Allergy Asthma Immunol 2006;97:92-7 (Pubitemid 44156344)
30. Gorska L, Chelmimska M, Kuziemski K, et al. Analysis of safety, risk factors and pretreatment methods during rush hymenoptera venom immunotherapy. Int Arch Allergy Immunol 2008;147:241-5
31. Kalogeromitros D, Makris M, Koti I, et al. A simple 3-day rush venom immunotherapy protocol: documentation of safety. Allergol Immunopathol (Madr) 2010;38:69-73
32. Spoerl D, Bircher AJ, Scherer K. Safety profile of hymenoptera venom immunotherapy (VIT) in monosensitized patients: lack of new sensitization to nontreated insect venom. J Investig Allergol Clin Immunol 2011;21:22-7
33. Wyss M, Cheitlin T, Stadler BM, et al. Immunotherapy with aluminum hydroxide adsorbed insect venom extracts (Alutard SQ): immunologic and clinical results of a prospective study over 3 years. Allergy 1993;48:81-6 (Pubitemid 23054580)
34. Mosbech H, Muller U. Side-effects of insect venom immunotherapy: results from an EAACI multicenter study. Allergy 2000;55:1005-10
35. Stumpf JL, Shehab N, Patel AC. Safety of angiotensin-converting enzyme inhibitors in patients with insect venom allergies. Ann Pharmacoter 2006;40:699-703
36. Rueff F, Przybilla B, Bilo MB, et al. Predictors of side effects during the buildup phase of venom immunotherapy for Hymenoptera venom allergy: the importance of baseline serum tryptase. J Allergy Clin Immunol 2010;126:105-11
37. Bilo MB, Antonicelli L, Bonifazi F. Purified vs. nonpurified venom immunotherapy. Curr Opin Allergy Clin Immunol 2010;10:330-6